NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $4.01 | Prev. Close $3.99 | Circuit Range N/A |
Day Range $3.95 - $4.18 | Year Range $1.64 - $5.05 | Volume 45,052 |
Average Traded $4.08 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $4.01 | $4.09 | +0.00% |
30-Jun-26 | $4.01 | $4.09 | +2.61% |
29-Jun-26 | $3.83 | $3.99 | +7.26% |
26-Jun-26 | $3.52 | $3.72 | +4.49% |
25-Jun-26 | $3.60 | $3.56 | -0.56% |
24-Jun-26 | $3.80 | $3.58 | -4.79% |
23-Jun-26 | $3.92 | $3.76 | -3.59% |